Cancer death rates in the U.S. took the “biggest single-year drop ever,” according to a new report by the American Cancer Society. Improvements in the screening and treatment of lung cancer, the 2nd most common cancer and leading cancer killer, are a main contributor to this positive trend. Julie Brahmer, M.D., Director of the Kimmel […]
Issues & Perspectives
World-class Care in a Community Setting
Posted by | Issues & PerspectivesIn June, The Johns Hopkins Kimmel Cancer Center’s Breast Center at Green Spring Station opened its doors to a brand new space in its existing suburban location. The new setting offers a few additional services and some truly special amenities. When patients come to the Kimmel Cancer Center clinic at Greenspring Station Pavilion III, they’ll […]
Helping Breast Cancer Survivors Reach Their Weight-Loss Goals
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, Research, SurvivorshipNumerous studies have shown that even a modest amount of weight loss can improve a variety of health-related metrics and quality of life for those who are overweight or obese. Attaining a healthy weight is important for breast cancer survivors, says new Kimmel Cancer Center breast cancer expert Jennifer Sheng, M.D. Studies have shown that […]
Not On My Watch – Dr. Arjun Gupta
Posted by | Issues & Perspectives, Patient StoriesDr Arjun Gupta discusses a 'Cancer Care Chronicles' essay he published in JAMA Oncology, titled ''Not On My Watch.'' In the essay, he shares his experiences as a first year clinical oncology fellow, while caring for a man with colon cancer. The essay is a tribute to the patient, who throughout the journey, taught Dr […]
Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention
Posted by | Issues & Perspectives, ResearchA national publication on cancer causes, prevention, detection and survivorship will have a Johns Hopkins cancer epidemiologist at the helm for 2019. Elizabeth Platz, M.P.H., Sc.D, is the co-leader for cancer prevention and control at the Johns Hopkins Kimmel Cancer Center. She was named as editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention (CEBP), one of […]
Moving for Melanoma of Delaware Supports Melanoma Research at Johns Hopkins
Posted by | Giving Back, Issues & PerspectivesMembers of the Johns Hopkins Melanoma Program participated in an annual 5K walk/run event and received funds raised by the event during a visit in February. The 5K event in Wilmington, Delaware, and sponsored by Moving for Melanoma of Delaware for the past 11 years raises money for melanoma research, community education and support patients and […]
Pancreatic Cancer Matters: Right Treatment at the Right Time
Posted by | Issues & Perspectives, pancreatic cancer, precision medicine, Research, treatmentOur collaborative team of scientists, physicians and allied health workers at the Johns Hopkins Kimmel Cancer Center specialize in translating science learned in the laboratory into exceptional clinical care. The Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care is a world leader in the diagnosis and management of pancreatic cancer, leading all […]
The Future of Pancreatic Cancer Treatments
Posted by | Issues & Perspectives, pancreatic cancer, Prevention/Screening, Research, treatmentJust eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances in treatment headed? Elizabeth Jaffee, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, describes explains in a 2018 interview on WYPR. http://www.wypr.org/post/why-pancreatic-cancer-so-deadly
Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers
Posted by | Issues & PerspectivesA guideline on guide the clinical practice of managing adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy continues to draw readers nearly a year after its publication. The document’s development, led by Julie Brahmer, M.D., co-director of the upper aerodigestive department in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and a professor of […]
Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, treatmentCombinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]